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Abstract
Burkholderia pseudomallei is an important human pathogen whose infection biology is still poorly understood. The
bacterium is endemic to tropical regions, including South East Asia and Northern Australia, where it causes melioidosis, a
serious disease associated with both high mortality and antibiotic resistance. B. pseudomallei is a Gram-negative facultative
intracellular pathogen that is able to replicate in macrophages. However despite the critical nature of its interaction with
macrophages, few anti-macrophage factors have been characterized to date. Here we perform a genome-wide gain of
function screen of B. pseudomallei strain K96243 to identify loci encoding factors with anti-macrophage activity. We identify
a total of 113 such loci scattered across both chromosomes, with positive gene clusters encoding transporters and secretion
systems, enzymes/toxins, secondary metabolite, biofilm, adhesion and signal response related factors. Further phenotypic
analysis of four of these regions shows that the encoded factors cause striking cellular phenotypes relevant to infection
biology, including apoptosis, formation of actin ‘tails’ and multi-nucleation within treated macrophages. The detailed
analysis of the remaining host of loci will facilitate genetic dissection of the interaction of this important pathogen with host
macrophages and thus further elucidate this critical part of its infection cycle.
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Introduction
The Gram-negative bacterium Burkholderia pseudomallei is a
serious environmental pathogen of man and the causative agent
of the often fatal disease melioidosis. Disease occurs following
exposure to contaminated water or soil, usually through cuts in
the skin or via inhalation, but the underlying mechanisms of
pathogenicity of B. pseudomallei to humans remain poorly
understood [1–3]. B. pseudomallei is endemic to S.E. Asia and N.
Australia where infections are associated with both antibiotic
resistance and high mortality rates (,50%). The ability of this
pathogen to infect via inhalation has necessitated its listing as a
potential bio-warfare agent [4]. The high rates of infection and
subsequent patient mortality therefore make B. pseudomallei a high
priority for research and vaccine development as no effective
vaccine currently exists [3,5]. During the establishment of success-
ful infection B. pseudomallei adheres to, survives and replicates
within host epithelial cells and macrophages by somehow
interfering with the cellular mechanisms which would otherwise
destroy them. Known bacterial factors affecting the interaction
with host cells include the bacterial capsule, and effectors delivered
by the type III and type VI secretion systems (T3SS and T6SS)
[5]. The Bsa T3SS and its delivered effector BopE is associated
both with invasion of non-phagocytic cells and also subsequent
vacuolar escape [6–10]. Type VI secretion system-5 (T6SS-5) is
specifically induced upon exposure to macrophages and also
appears to play a role in intracellular survival [11]. Once inside the
macrophage the pathogen induces macrophage cell fusion leading
to the formation of so called Multi-Nucleated Giant Cells or
MNGCs, a process key to both intracellular replication and
bacterial persistence but one for which the molecular basis is
obscure [12]. Once intracellular replication of the pathogen has
reached a critical point the bacteria induce host cell death, again
by an unknown mechanism, and subsequently escape host cells to
establish secondary infections [3]. Importantly, different Burk-
holderia strains show a wide range of different interactions with
human macrophages, ranging from no effect, to host cell apoptosis
and capase-1-dependent lysis [3,13]. This range of different
responses to macrophages suggests that the complement of anti-
macrophage virulence factors encoded by the genome of different
strains may differ dramatically and may also indicate potential
functional redundancy amongst such factors. Importantly, con-
ventional genomic analysis has failed to identify homologues of
known toxins in B. pseudomallei [14]. Thus for example whilst a
cytolethal exotoxin has been identified in the culture filtrate of B.
pseudomallei the toxin remains to identified and encoding gene
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characterised [15]. Here we therefore perform a simple gain of
function screen in recombinant Escherichia coli to identify the full list
of loci potentially encoding toxins, or other factors, with anti-
macrophage activity.
To perform the screen we chose the strain B. pseudomallei
K96246, a clinical isolate, whose genome, of two chromosomes,
has been fully sequenced [14]. Chromosome 1 (4.07 Mb)
represents 56% of the genome and contains a higher proportion
of coding sequences (CDSs) than the smaller chromosome 2
(3.17 Mb). The CDSs on chromosome 1 are thought to be largely
involved in housekeeping functions, such as metabolism, whereas
those on chromosome 2 appear to encode accessory functions
facilitating adaptation to atypical conditions, osmotic protection,
secondary metabolism, iron acquisition and gene regulation [14].
There are predicted to be at least 16 horizontally acquired
genomic islands located in the B. pseudomallei genome which often
contain genes encoding hypothetical virulence factors [16].
Libraries of recombinant E. coli each carrying end-sequenced
B. pseudomallei genomic fragments (fosmids or Bacterial Artificial
Chromosomes (BACs)) were used to identify loci encoding factors
cytotoxic to the murine macrophage cell-line J774-2. The end-
sequences of multiple positive clones recovered from the screens
were aligned on to the sequenced genome in order to identify
and confirm the precise configuration of the loci involved [14].
Such a rapid and simple gain of function screen proves an
extremely useful tool for dissecting pathogens displaying func-
tional redundancy of multiple virulence factors and toxins. Such a
multiplicity of bacterial virulence factors encoded within a single
genome can frustrate attempts to dissect virulence via conven-
tional mutagenesis. For example, targeted knock-out of the toxin
Mcf1 in Photorhabdus bacteria does not dramatically decrease anti-
insect virulence due to the remaining copy of a second toxin
encoding gene Mcf2 and a host of other remaining virulence
factor encoding genes that remain unaffected [17]. Such ‘func-
tional redundancy’ can therefore potentially mask the important
role of specific gene candidates if other virulence factors com-
pensate for the expected change in the resulting single mutant
phenotype. Given the wealth of potential genes encoding putative
virulence factors in the different genomes of B. pseudomallei, here
we use this gain of function screening technique to reveal over
100 loci encoding anti-macrophage factors scattered across
the two different chromosomes of this bacterial genome. Such
analyses will facilitate the identification and follow-up of effec-
tor proteins and small molecules that influence the potentially
complex interaction between Burkholderia bacteria and host
macrophages.
Results
Loci encoding anti-macrophage factors are distributed
over both chromosomes
We screened genomic libraries of B. pseudomallei K96243 in BAC
and fosmid clones for activity towards J774-2 macrophages. To
identify and confirm anti-macrophage encoding loci in the B.
pseudomallei genome the end-sequences from positive library clones
(clones shown to reduce macrophage viability by .40 %) were re-
assembled onto the sequenced genome. Each locus was defined by
the minimum region of genetic overlap formed by a cluster of
two or more positive clones. Using these criteria, a total of 59
anti-macrophage encoding loci were identified on chromosome 1
and 54 on chromosome 2. Details of the loci, the predicted
open reading frames that they contain and associated BLAST
matches are provided in detail in the supporting information
(Table S1 and S2).
The screen reveals a broadly even distribution of anti-
macrophage associated loci across both chromosomes with some
notable exceptions (Figure 1). For example, on chromosome 1
there is a 0.6 MB region between 2,016,700 and 2,634,300 bp
containing only a single region of interest. The overall density of
hits is higher on chromosome 2, especially in view of its smaller
size. Interestingly, target loci were found either directly within, or
closely associated with, 11 out of the 16 genomic islands of strain
K96243. Further, almost all of the hits are associated with regions
of low G+C content (Figure 1). Both of these observations are
consistent with the anti-macrophage loci being associated with
genomic islands (GIs) and/or being recently horizontally trans-
ferred. A large cluster of positive loci are associated with GI 8 on
chromosome 1 and GI 16 on chromosome 2. GI 8 is described as
an island containing various virulence related factors including
hemolysin, YadA, transport and several regulatory proteins [14].
GI 16 contains a hemagluttinin-related protein (BPSS2053)
mutation of which has been shown to reduce adherence to human
buccal epithelial cells [18]. However, approximately 35% of the
genes contained within the B. pseudomallei GIs encode hypothetical
proteins and their exact functions therefore remain unknown [18].
Several broad functional classes were repeatedly predicted for
the anti-macrophage loci identified (Figure 2): There are 14
predicted regions in K96243 containing putative secondary
metabolite synthesis genes, 3 on chromosome 1 and 11 on
chromosome 2. Six loci isolated by the screen contained clusters of
genes predicted to encode non-ribosomal peptide synthetases
(NRPSs) and polyketide synthases (PKSs). Genes involved in signal
response and regulation (methyl-accepting chemotaxis proteins,
two-component sensor systems, AraC and LysR family regulators)
were also repeatedly detected. Numerous phage-related elements
flank positive loci indicating that these may be mobile elements
associated with insertion events, and could be responsible for the
potential transferral of virulence factors between B. pseudomallei
strains. A number of genes which could promote the survival of B.
pseudomallei in host cells were also identified in the regions of
interest including genes encoding factors responsible for resistance
to drugs, heavy metals and reactive oxygen species (sodB and katB).
Regions associated with anti-macrophage activity also include
CDSs relating to adhesion (hemagglutinin, YD repeat proteins)
and biofilm formation (lipopolysaccharide, acetolactate synthase).
However the largest predicted function categories associated with
the anti-macrophage loci were either toxin/enzyme related
(hemolysins, proteases, phospholipases) with 44 associated CDSs
within loci, or proteins involved in transport/secretion (ABC
transporters, efflux transporters, and proteins involved in type III
and VI secretion) with 84 related CDSs within positive loci.
Several of the anti-macrophage loci encode putative toxins. For
example, BPSS1993 encodes a metalloprotease A, termed MrpA,
a 47 kDa protein negatively regulated by QS molecules, a putative
hemolysin with homology to Bacillus cereus hemolysin III
(BPSS0803) and LasA elastase from Pseudomonas aeruginosa
(BPSL0624). One locus also contains a gene (BPSS0067) encoding
phospholipase – PLC-3 a putative non-hemolytic phospholipase C
with an N-terminal twin-arginine translocation (Tat pathway
signal sequence) which was transcriptionally up-regulated in a
hamster model of infection and increases the LD50 of test animals
dramatically [19]. Interestingly, the phospholipases PLC-1
(BPSL2403) and PLC-2 (BPSL0338) were not detected in this
screen.
The genome of B. pseudomallei K96243 contains six gene clusters
encoding putative T6SSs [11]. Whilst, again, the host E. coli used
in the library screens were not armed with any specific type III or
type VI secretion systems, several positive loci encode putative
Anti-Macrophage Factors from Burkholderia
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Figure 1. The distribution of positive loci on chromosomes 1 and 2. Outer pair of concentric circles represents both coding strands of the B.
pseudomallei genome. The next ring in shows the location of current genomic islands (dark blue) and putative genomic islands (turquoise) and the
innermost ring the location of the anti-macrophage associated loci (red). Also shown is the percentage of G+C content and the GC deviation plot
(.0%= olive, ,0%= magenta).
doi:10.1371/journal.pone.0015693.g001
Figure 2. Distribution of features within positive loci on chromosome 1 and 2. Graph showing the number of CDSs for different functional
classes found within anti-macrophage loci identified by the screen on both chromosomes. The majority of CDSs identified within positive loci are
associated with exoprotein/ enzymic activity and transport or secretion systems.
doi:10.1371/journal.pone.0015693.g002
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VgrG-like T6SS-related proteins. Some VgrG effector proteins
have been inferred to induce host cell toxicity by ADP-ribosylation
of actin, as well as performing a role in formation of the secretion
machinery itself [20,21]. B. pseudomallei T6SS-5 is induced upon
exposure to macrophages and plays an important role in the
intracellular survival of the pathogen [11]. However, a genomic
clone containing the entire T6SS-5 cluster was not detected in the
current study, presumably as either it did not fit entirely within one
of the cloned library fragments or because other elements
necessary for its production in the recombinant E. coli used were
absent.
There are a total of 105 predicted functional ABC systems
encoded within the genome of strain K96243 [22] and 22 of these
were identified within our list of anti-macrophage encoding loci
(14 on chromosome 1 and 8 on chromosome 2). Within this
category of hits the positive ABC transporter encoding loci include
two class I export systems. One region of interest detected contains
the LPS biosynthetic operon BPSL2672-BPSL2688 containing the
class I wzt ABC transporter, confirming the potential role of LPS
in interaction with macrophages [23,24] and suggesting that an
active form of LPS can be correctly assembled by the host E. coli
used for library construction. The second class I ABC system
detected, BPSL3092-BPSL3094 is classified as involved in
hemolysin export, however there are no identified hemolysins
associated with this system in K96243 [22]. However, this ABC
system neighbors two putative peptidase encoding genes whose
products may be exported. Further, we note that many of the
predicted proteins from positive candidate regions are thought to
encode outer membrane proteins, again consistent with their
potential interaction with host macrophages and their presumptive
display on the outer membrane of the recombinant E. coli used in
the screen. In summary, given that the host E. coli used in the
screen (DH10B and EPI-300-T1R) lack the specific secretion
machinery (e.g. T3SS or T6SS) necessary for delivery of many
types of known effectors, the clusters of anti-macrophage loci
uncovered here appear to be able to reconstitute toxicity in the
recombinant E. coli either using systems still present (e.g. type 1
secretion) or by using transporters (e.g. ABC) or synthetic
machinery (e.g. liposaccharide biosynthesis) also encoded within
the positive clones/clusters.
Cellular phenotypes of anti-macrophage factors
In order to begin to characterize the range of likely cellular
phenotypes caused by this plethora of new candidate anti-
macrophage factors we focused on the four positive clusters
diagrammed in Figure 3. These clusters carry CDSs encoding
factors related to secondary metabolism (NRPS/PKS), candidate
enzymes, bacterial adhesins and unclassified hypothetical proteins.
The NRPS/PKS encoding region BPSS1263-BPSS1269 has
homology to the Syringolin A (SylA) producing NRPS cluster
from the plant pathogen Pseudomonas syringae [25]. SylA is a
proteome inhibitor and is cytotoxic to a number of mammalian
cell types, including carcinoma derived cell lines, such compounds
are therefore of interest as potential anticancer drugs [25,26].
Macrophages treated with positive clones containing the SylA-like
NRPS cluster show aberrations in nuclear morphology, with
nuclei becoming enlarged and showing an irregular (here termed
‘corrugated’) perimeter. The cytoskeleton of the treated cells also
becomes amorphous, punctate and collapses around the nucleus
itself (Figure 4 C).
Thirty of the anti-macrophage loci contained ‘hypothetical
proteins’ whose potential functions cannot be predicted from
homology with known virulence factors. BPSL0590 and
BPSL0591 are CDSs found in a positive locus on chromosome 1
which encode such hypothetical proteins. However closer
examination of protein predictions from these two CDSs does
reveal some limited homology to known toxins from other
bacterial pathogens suggesting they may encode novel toxins.
Position-specific-iterative blast (psi-BLAST) reveals that this
putative membrane protein also has a central region similarity to
the Rhs associated core sequence (1.98e-10) and to the middle N
and C-terminal domains of a Photorhabdus luminescens insecticidal
Toxin complex (Tc) component protein, specifically TcdB N and
C terminal regions (7.87e-36 and 7.90e-29 respectively). The N-
terminal region of BPSL590 has homology to the N-terminal of
Salmonella enterica plasmid virulence associated protein SpvB (1.03e-
09). The function of the N-terminus of SpvB remains unknown but
shares sequence similarity to the N-terminal domain of P.
luminescens toxin TcaC, the function of TcaC is largely unclear
but is thought to act as a potentiator modifying other toxin
components and it is required to reproduce full toxicity of the
Toxin complexes via recombinant expression [27,28]. The
catalytic domain of SpvB responsible for ADP-ribosylation of host
cell actin is located at the C-terminus. Depolymerisation of host
cell actin by SpvB causes destruction of cytoskeletal structure and
cell death via apoptosis [28,29]. Structural predictions for SpvB
suggest that the C-terminus is linked to the N-terminus via a poly-
proline region. This suggests that it could represent a class of
modular toxins in which the active/enzymic region is linked to the
N-terminus whose function remains undefined.
The neighbouring hypothetical protein BPSL0591 also displays
predicted homology to a P. luminescens insecticidal Tc protein,
specifically TccB. Macrophages treated with lysate from clones
encompassing these toxin-like genes show both formation of
multinucleated cells and apoptotic nuclei, (Figure 4B). These results
suggest that this is an exciting new genomic island encoding toxins
with putative activity on the actin cytoskeleton or the small GTPases.
The third cluster chosen for further phenotypic analysis
(Figure 3C) carries a gene predicting a protein with putative
phospholipase D activity (BPSS1381), neighbouring an endonu-
clease/exonuclease/phosphatase family protein (BPSS1382). This
positive gene cluster also contains a putative membrane magne-
sium transporter protein. Macrophage monolayers treated with a
preparation of clones (E. coli cells, whole cell lysate and
supernatant) containing this region of interest show a dramatic
decline in cell density, indicating a potent degree of cytotoxicity.
Macrophages surviving such treatment become distended with
little remaining cytoskeletal or nuclear structure (Figure 5A).
The fourth cluster chosen for follow up analysis contains two
CDSs encoding a putative hemagglutinin and with homology to
the large filamentous hemagglutinin precursor, FhaB, (BPSS1727)
and hemolysin activator-like protein precursor, FhaC (BPSS1728)
of Bordetella pertussis (Figure 3D). The B. pertussis filamentous
hemagglutinin (FHA) is an adhesin and facilitates attachment to
the host cell during infection following secretion which is
dependent on FhaC [30]. Alongside this role in attachment,
FHA is also described as having accessory functions, including
pro-apoptotic activity towards macrophages [31]. Macrophages
exposed to preparations of clones containing the B. pseudomallei
hemagglutinin-like gene display a very interesting phenotype with
formation of dramatic actin projections or ‘tails’ extending towards
neighboring cells from shrunken cell bodies containing condensed
nuclei.
Fractionation of bioactivity from the SylA-like gene
cluster
Finally, to demonstrate how bioactivities from positive gene
clusters can be further confirmed and fractionated, we carried out
Anti-Macrophage Factors from Burkholderia
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a more detailed analysis of the gene cluster encoding the
Burkholderia ‘SylA’ homolog, here termed BylA. The SylA gene
product is a small molecule secreted into the supernatant of
cultures of P. syringae bacteria [32]. Cell-free supernatants from
recombinant E. coli clones carrying the Burkholderia BylA encoding
cluster also show strong cytotoxic activity and remaining
macrophages from treated monolayers display a shrunken and
rounded phenotype (Figure 6). Such activity is absent from the
cytosolic fraction of the same preparations showing that the
bioactive component, BylA, is secreted.
Discussion
The bacterium B. pseudomallei has a complex and poorly
understood infection cycle involving periods in the environment
and periodic infection of man. Although a serious human
pathogen many of the virulence mechanisms of B. pseudomallei
remain to be elucidated. Burkholderia infect and replicate within
host macrophages and subsequently induce macrophage cell death
but the mechanisms whereby they effect anti-macrophage activity
are not completely understood. Here we have described a gain of
function screen which successfully and rapidly detected over 100
anti-macrophage encoding gene clusters within genomic libraries
of B. pseudomallei expressed in recombinant E. coli. This screen pulls
out genomic factors either equipping E. coli with toxic elements
which kill macrophages or an improved ability to evade them or
improve growth, thus killing the cells by overwhelming/ nutrient
depletion (e.g. hydrogen peroxide scavenging, drug export or
biofilm formation). In this light we will now briefly discuss three
aspects of the data and its generation. First, the overall distribution
of the screening hits across the two chromosomes of B. pseudomallei.
Second, the problems and pitfalls associated with the delivery of
Figure 3. Genetic maps of four putative regions of interest. Genomic organisation of four anti-macrophage loci isolated by the screen
representative of the main functional classes identified. Genes putatively involved in anti-macrophage activity are highlighted in red and roles of
other genes in the region are provided in the figure legend based on the original genome annotation and BLASTX analysis. The number of
overlapping positive clones isolated by the screen that identify these as regions of interest are shown in blue below the ORF maps. BPSS1263-
BPSS1269 encodes NRPS/PKS genes involved secondary metabolism including a putative efflux system and have homology to the SylA producing
genes of P. syringae. BPSL0584-BPSL0591 encodes two hypothetical proteins (BPSL0590 and BPLS0591) with some homology to known toxins
including SpvB of Salmonella enterica and Toxin complex components of Photorhabdus luminescens and may represent a novel toxin cluster. These
genes neighbour phage-related elements suggesting possible horizontal acquisition. A Phospholipase D-like protein is represented (BPSS1381),
flanked by hypothetical proteins and core genome genes and a hemagglutinin/hemolysin related region BPSS1720-BPSS1728 with similarity to the
filamentous hemagglutinin FHA of Bordetella pertussis.
doi:10.1371/journal.pone.0015693.g003
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potential effectors from the recombinant E. coli and their uptake by
the target macrophages. Third, and finally, we will spend some
time discussing the likely nature of the positive clusters themselves
and how they may inform our future understanding of Burkholderia
infection biology.
Distribution of positive gene clusters
The genomic locations of the gene clusters encoding anti-
macrophage effectors and compounds are worthy of brief
discussion before a detailed discussion of the clusters themselves
and their potential role in infection biology. Thus although
positive loci are distributed relatively uniformly across the two
chromosomes of B. pseudomallei many are specifically associated
with genomic islands and/or regions of altered GC content.
Genomic islands are often linked to symbiosis or pathogenicity
[16] and the co-location of anti-macrophage clusters within, or
next to, GIs may confirm their suspected roles as pathogenicity
islands. An alternative explanation for the association of positive
loci with regions of low % GC could be that the DNA encoding
them is closer to the % GC content of the host E. coli, and
therefore these regions may be more preferentially expressed in
comparison to those with high %GC.
Secretion from recombinant E. coli and effector uptake
by macrophages
Given the relatively crude and simple nature of the screen and
given that the recombinant E. coli are not in any way secretion
proficient or enhanced (e.g. via the addition of a T3SS), it is
interesting to speculate how the anti-macrophage factors (proteins,
small molecules or modified external structures such as LPS) are
released from the host E. coli and indeed how they are taken up by
(or contacted by in the context of ‘displayed’ molecules such as
LPS) the target macrophages in cell culture. In this latter respect it
is critical to note that the presence of some intact E. coli in the
crude lysates applied to the macrophages appears necessary for
toxicity in some cases, possibly by facilitating uptake of, or
response to, recombinant factors. In contrast to much of the
previous work on the three T3SSs in Burkholderia we would not
expect T3SSs or their effectors to be recovered as positives in this
system for a number of reasons. First, given that the size of the
Figure 4. Cytotoxicity of positive clones containing regions encoding hypothetical toxin-like proteins and a SylA-like small
molecule. Macrophages treated with crude lysate prepared from E. coli carrying vector only control (A) and those treated with clones expressing
hypothetical toxin-like proteins with homology to the N-terminal of SpvB of S. enterica and Toxin complex components of P. luminescens (B) and a
SylA-like component (C) for 24 h and stained with TRITC-conjugated phalloidin (red) and Hoechst 33258 (blue) to reveal cytoskeletal and nuclear
structures. Macrophages treated with clones encoding the toxin- like homolog display both multi-nucleation (white arrow) and apoptosis (yellow
arrow). Macrophages treated with the SylA-like (BylA) clone lysates are shrunken and display a punctate actin cytoskeleton with regions of
condensation (white arrows). Scale bars = 10 mm.
doi:10.1371/journal.pone.0015693.g004
Anti-Macrophage Factors from Burkholderia
PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e15693
gene clusters encoding a complete T3SS can be extensive we were
not expecting to recover T3SS related hits in the size range
genomic fragments currently used (10–40 kb). More importantly
we did not ‘arm’ the recombinant E. coli used in the library
screening with a functional T3SS and we therefore also did not
expect to identify any T3SS delivered effectors (in the absence of a
clone encompassing an entire native T3SS). Finally, in relation to
secretion, a number of positive clusters on chromosome 2 contain
T6SS related CDSs. The precise role of T6SSs are largely
uncharacterized but expression of one system has been shown to
be induced upon invasion of macrophages. However mutation
studies showed no alteration in invasion or intracellular survival
suggesting a role in another area of pathogenesis [11]. In
conclusion, and as predicted, the T3SS and T6SSs involved in
invasion were not detected by this screen which focused on non-
T3 and T6SSs largely by virtue of their predicted absence from the
average size of cloned genome fragments.
Cluster composition and likely effectors
In reference to the genetic composition of the clusters
themselves, phenotypic analysis of four regions of interest detected
by the screen begin to link activity of the gene products to some of
the important phenotypes associated with Burkholderia infection and
may allow us to begin to answer how bacterial cells persist within
and spread between infected macrophages. Several of these
positive gene clusters are therefore worthy of further discussion
here. The first such region contains homology to the B. pertussis
filamentous hemagglutinin or FHA. FHA is an adhesin which
facilitates attachment to host cells during infection. Alongside this
role in attachment, FHA also has other accessory functions,
including pro-apoptotic activity towards host macrophages [31]
and it is suggested that this may be used to combat the host cell-
mediated immune response whilst infection is being established.
Positive clones recovered in our screen, and containing a B.
pseudomallei region homologous to FHA, cause dramatic actin
protrusions from macrophages and apoptotic nuclei. It should be
noted that B. pseudomallei travel down actin protrusions in order to
spread to neighboring cells via actin based motility [12] and that
the effector, BimA, has been observed as required for this activity
as mutants in this gene do not induce formation of actin tails [33].
Figure 5. Disruption of macrophages by clones encoding a phospholipase D-like and hemagglutinin-like effector. Treatment of
macrophages with lysate from clones carrying a putative phospholipase D gene for 24 h results in a loss of cytoskeletal structure and abnormalities
within the nucleus (A). In contrast, macrophages treated with lysate containing a hemagglutinin-like protein for 24 h (B) suffer severe alterations in
their actin cytoskeleton producing pronounced actin filaments (white arrows). Scale bars = 10 mm.
doi:10.1371/journal.pone.0015693.g005
Figure 6. Bioactivity of clones encoding the SylA homolog is
associated with the cell free supernatant. Fraction screening of
clones containing the SylA-like region reveals that cytotoxicity is not
present in the cytosolic fraction. F-actin cytoskeleton staining of the
treated cells reveals an intact macrophage monolayer (x10) with cells
displaying a normal phenotype. Cytotoxicity is found in the bacterial
cell-free supernatant a clear reduction in the number of macrophages in
the monolayer can be seen. Higher magnification reveals cytoskeletal
collapse and cell shrinkage implying that the anti-macrophage moiety is
secreted. Scale bars: x10= 50 mm, x60= 10 mm.
doi:10.1371/journal.pone.0015693.g006
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These FHA homolog induced actin protrusions may therefore play
a central role in regulating the actin cytoskeleton for adherence of
B. pseudomallei to the host cell or perhaps act as an effector, like
BimA, involved in the process of intracellular spread itself.
Following attachment, B. pseudomallei is capable of invading and
replicating within both phagocytic and epithelial cells either
entering via cell mediated phagocytosis or via the combined effects
of Bsa T3SS and its internally delivered effector, BopE [9]. Once
inside the host cell B. pseudomallei cells exhibit actin based motility
and induce host cell fusion, resulting in the formation of ‘multi-
nucleated giant cells’ or MNGCs. Here we have described both a
MNGC-like and pro-apoptotic phenotype linked to a novel toxin
cluster containing genes predicting proteins with homology to the
Salmonella enterica virulence associated protein SpvB and different
components of the Toxin complexes (Tcs) of the insect pathogen
Photorhabdus luminescens. Whilst we have not designated specific
phenotypes to specific genes within this novel cluster we suggest
that these genes are responsible for reorganization of the actin
cytoskeleton possibly directly or via effects on the small Rho
GTPases. Further, this suggests that the formation of MNGCs in
Burkholderia infected hosts can be induced by a single factor,
independently of the actin-based motility mechanism. Further
work addressing the process of secretion and mechanism of action
of this novel toxin cluster will be important in understanding the
role this region plays in MNGC formation.
Anti-macrophage activity is also seen in response to positive
clones containing a phospholipase D domain protein. A PLD gene
encoding a protein with phospholipase D activity is associated with
phagosomal escape in Rickettsia prowazekii [34]. Mutants of PLD in
Rickettsia show attenuated virulence in guinea pigs, and animals
immunized with the mutant strain are protected from subsequent
challenge with the wild-type strain. Phospholipase D is also a
major virulence determinant of Corynebacterium pseudotuberculosis and
plays a key role in macrophage death [35]. Mutation of PLD genes
in the pathogens Corynebacterium pseudotuberculosis and Rickettsia
prowazekii have therefore shown promise as a strategy for
development of attenuated strain vaccines [34,36]. Again the role
of the PLD-like gene in the interaction of Burkholderia with host
macrophages therefore warrants further attention.
Finally, many of the positive gene clusters are associated with
the production of NRPS/PKS systems which are predicted to
make small molecules or peptides. Whilst it is often possible to
predict the likely structure of the small molecules made via the
unique combinations of PKS modules present, the role of these
gene products in bacterial virulence is often less clear. We focused
on one such positive region in B. pseudomallei which appears to
encode a molecule similar to the proteome inhibitor SylA from P.
syringae, which we term BylA here. SylA is of extreme interest as it
shows good activity against carcinoma derived cell lines and BylA
may therefore be similarly interesting and important. We have
shown that gene clusters encoding BylA produce an active
compound cytotoxic towards macrophages when expressed in
recombinant E. coli. Moreover, this bioactivity can be localized to
the supernatant of the recombinant E. coli culture suggesting that it
does indeed correspond to a secreted small molecule similar to
SylA.
Conclusions and outlook
Current models for studying the factors involved B. pseudomallei
virulence include gene knockout within the pathogen and
subsequent testing for avirulence using in vivo models. However,
B. pseudomallei has a large genome with high genomic plasticity
between strains and subspecies, and is designed to survive in a
diverse array of environmental settings. Different strains of B.
pseudomallei possess very different genetic complements suggesting
there may be a variety of mechanisms for producing the same
disease outcome. These factors imply that functional redundancy
is highly likely among the mechanics of infection and that other
genes may compensate for those mutated, and therefore mask the
loss of virulence associated with any single gene knock-out or
knock-down. The gain-of-function screen described here allows us
to look at the effects of single factors provided that their potency
can be reconstituted in recombinant E. coli. Characterisation of
such leads will allow us to understand poorly understood
mechanisms behind the pathogenicity of this organism and also
present us with putative targets for vaccine and drug development.
For screening other bacteria, such as Gram-positives, and indeed
other microbes, such as fungi, we can envisage that such gain of
function screens could be conducted in alternative and more
appropriate hosts such as Bacillus or indeed yeast. Such studies
would then allow for the rapid and facile screening of other
microbial genomes for virulence factors for which similar assays
can be derived.
Materials and Methods
Genomic library construction
A combination genomic BAC and fosmid libraries, were used in
these experiments. The BAC library was constructed in E. coli
DH10B containing pBACe3.6 with an average B. pseudomallei
DNA insert size of 20 kb originally employed for the Sanger
genome sequencing project [14]. The Fosmid library was created
using the CopyControl Fosmid Library Production Kit with E. coli
EPI-300-T1R (Epicentre) with an average insert size of 40 kb.
BAC and fosmids libraries were arrayed into 96 well microplates
to give ,10X coverage of the genome. All clones in the libraries
were then end-sequenced to facilitate location of their paired ends
in the genome.
Macrophage Toxicity Screening
Library plates were replicated into 96 well microplates
containing 100 ml Luria Bertani medium plus 12.5 mg ml21
chloramphenicol as the selective antibiotic for both the BAC and
Fosmid library clones. Replicate library plates were grown for 24 h
at 350 rpm, 37uC and cultures were subsequently harvested by
centrifugation at 4,000 rpm for 10 minutes. 80 ml of supernatant
aspirated the remaining bacterial pellet and supernatant mixed
thoroughly with 80 ml 1 mg ml21 lysozyme in Phosphate Buffered
Saline solution. Plates were then incubated at room temperature
for a minimum of 1 h, followed by three freeze-thaw cycles before
centrifugation at 3,000 rpm for 10 minutes. 80 ml of the crude
lysates were removed and applied to 96 well plates containing
confluent monolayers of the BALB/c monocyte macrophage cell
line J774-2 (from The European Collection of Cell Cultures,
ECACC) in Dulbecco’s Modified Eagles Medium (DMEM)
supplemented with 10% foetal bovine serum, 5% non-essential
amino-acids and 5 mg ml21 chloramphenicol. Crude lysates and
macrophages were co-incubated for 24 h (37uC, 5% CO2). Media
on the macrophages was then replaced with phenol red-free
DMEM containing an antibiotic cocktail: ampicllin 100 mg ml21,
gentamicin 50 mg ml21, penicillin 100 U ml21, streptomycin
100 mg ml21, kanamycin 100 mg ml21 and tetracycline 5 mg ml21
and incubated with the macrophages for 2 h (37uC, 5% CO2) to
destroy live bacteria which would otherwise affect the readout of
the cell viability assay. Macrophage cell viability was assessed using
the XTT assay [37]. Candidate positive BAC and Fosmid library
clones were selected for their ability to reduce viability by 40% or
more comparative to untreated cells.
Anti-Macrophage Factors from Burkholderia
PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e15693
Candidate Identification
BAC and fosmid end sequences were aligned to the Burkholderia
chromosomes using SSAHA2 version 2.5 [38] and the output
exported in gff format. The alignments were manually checked to
verify their integrity and to ensure the correct distance (10–20 kb)
between mate-paired sequences. Once the gff had been edited it
was uploaded to a custom Burkholderia GBrowse database, and the
BAC and fosmid sequences were displayed as separate tracks in
the GBrowse detail panel. This allows for the identification of
‘clusters’ of clones containing putative virulence factors. These
positive ‘clusters’ form due to the multiplicity of genomic coverage
within a fosmid library, for example, up to ten clones encoding an
anti-macrophage toxin might be recovered from a library
possessing 10X genomic coverage. The minimum region of
genetic overlap within clusters was examined for candidate CDSs
or operons using the annotated K96243 genome and BLASTX
analysis [6]. The distribution and location of positive loci on
chromosome 1 and 2 were diagrammed using DNAPlotter [39].
Characterisation of Cellular Phenotypes
Confluent monolayers of J774-2 macrophages on glass cover-
slips were treated with equivalent volumes of crude lysates
(prepared as described above) from clones identified as containing
regions of interest and co-incubated for 24 h. Coverslips were then
washed in sterile 1X PBS before fixing with 4% paraformaldehyde
(w/v) in PBS for 15 min. Coverslips were then washed in 1 X PBS
and immersed in a fresh solution of ammonium chloride in 1X
PBS (13.3 mg/ml) for 15 minutes, at room temperature followed
by washing in 1X PBS. Macrophages were permeabilised by
covering with 0.2% Triton X-100 in 1X PBS for 15 minutes.
Staining of the filamentous actin cytoskeleton was carried out with
TRITC conjugated phalloidin (Sigma), at a 1/500 dilution in 1X
PBS by inverting the coverslip onto a 60 ml drop of the staining
solution and incubating at room temperature in the dark for 1 h.
Following incubation the coverslips were washed 365 minutes in
1X PBS with the first wash containing 0.12 mg/ml21 Hoechst
33258 (Sigma) to stain the nuclei. A final wash by brief immersion
2X in distilled water is then made and coverslips mounted onto
slides using ProLong Gold Antifade (Molecular Probes, Invitrogen)
before visualization using fluorescence microscopy. For fraction
screening of the SylA homolog a single colony of a BAC library
clone containing the SylA region of homology was picked and
grown for 24 h in LB plus 12.5 mg ml21 chloramphenicol.
Bacteria were harvested by centrifugation at 7,000 rpm for 5
minutes and the culture supernatant removed. Cell-free superna-
tant was prepared by filter-sterilising with a 0.22 mm syringe-
driven filter unit (Millipore). The cytosolic fraction was prepared
by re-suspending the bacterial pellet in 1X PBS and sonicating the
mixture. The resultant sonicated product was centrifuged at
10,000 rpm for 15 min. to remove cell debris from the cytosol
preparation. Supernatant and cytosol fractions were applied to
J774 macrophage monolayers at 1:5 (v/v) supernatant or cytosol:
culture media and co-incubated for 24 h before fixing and staining
as described.
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